157 related articles for article (PubMed ID: 1313157)
1. Down-regulation of central receptors for thyrotropin-releasing hormone in kappa opiate agonist-induced abstinence in the rat.
Bhargava HN; Gulati A; Rahmani NH
Neuropharmacology; 1992 Feb; 31(2):137-41. PubMed ID: 1313157
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
Rahmani NH; Gulati A; Bhargava HN
Pharmacology; 1991; 43(3):156-62. PubMed ID: 1663623
[TBL] [Abstract][Full Text] [Related]
3. Effect of chronic administration of U-50,488H, a kappa-opioid receptor agonist, on central dopamine D2 receptors of the rat.
Veeranna ; Reddy PL; Bhargava HN
Eur J Pharmacol; 1993 Apr; 235(1):23-30. PubMed ID: 8390939
[TBL] [Abstract][Full Text] [Related]
4. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
Bhargava HN; Gulati A; Ramarao P
J Pharmacol Exp Ther; 1989 Oct; 251(1):21-6. PubMed ID: 2552075
[TBL] [Abstract][Full Text] [Related]
5. Abstinence from U-50,488H, a kappa-opiate receptor agonist, decreases the binding of [3H]DPAT to 5-HT1A receptors in the hypothalamus of the rat.
Reddy VP; Bhargava HN
Neuropharmacology; 1992 Dec; 31(12):1243-9. PubMed ID: 1470300
[TBL] [Abstract][Full Text] [Related]
6. Binding characteristics of [3H]SCH 23390 in spinal cord and discrete brain regions of kappa-opiate tolerant-dependent and abstinent rats.
Bhargava HN; Gulati A; Ramarao P
Pharmacology; 1991; 42(3):121-7. PubMed ID: 1647533
[TBL] [Abstract][Full Text] [Related]
7. beta-Endorphin-like immunoreactivity in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and -abstinent rats.
Bhargava HN; Matwyshyn GA; Rattan AK; Koo KL; Tejwani GA
J Pharmacol Exp Ther; 1994 Feb; 268(2):856-61. PubMed ID: 8113998
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of [3H][3-MeHis2]thyrotropin releasing hormone recognition sites in the rat brain by tifluadom, a kappa opiate receptor agonist.
Das S; Bhargava HN
Neuropharmacology; 1987 Aug; 26(8):1141-6. PubMed ID: 2889163
[TBL] [Abstract][Full Text] [Related]
9. Modification of the binding of [3H]MK-801 to brain regions and spinal cord of rats treated chronically with U-50,488H, a kappa-opioid receptor agonist.
Bhargava HN; Kumar S
Brain Res; 1997 Feb; 749(2):347-50. PubMed ID: 9138737
[TBL] [Abstract][Full Text] [Related]
10. Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist.
Bhargava HN; Ramarao P; Gulati A
Eur J Pharmacol; 1989 Mar; 162(2):257-64. PubMed ID: 2542058
[TBL] [Abstract][Full Text] [Related]
11. The effect of U-50,488H tolerance-dependence and abstinence on the levels of dynorphin (1-13) in brain regions, spinal cord, pituitary gland and peripheral tissues of the rat.
Bhargava HN; Matwyshyn GA; Rattan AK; Koo KL; Tejwani GA
Brain Res; 1993 Jan; 600(1):151-5. PubMed ID: 8093675
[TBL] [Abstract][Full Text] [Related]
12. Effects of acute and chronic administration of dizocilpine on the pharmacological responses to U-50,488H and brain and spinal cord kappa-opioid receptors in the rat.
Bhargava HN; Matwyshyn GA; Gudehithlu KP
Pharmacology; 1995 Nov; 51(5):323-30. PubMed ID: 8584584
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of brain and spinal cord K-opiate receptors in spontaneously hypertensive, Wistar-Kyoto normotensive, and Sprague-Dawley rats by chronic treatment with U-50, 488H.
Bhargava HN; Gulati A; Ramarao P
Biochem Pharmacol; 1991 Jun; 42(1):25-9. PubMed ID: 1648922
[TBL] [Abstract][Full Text] [Related]
14. Methionine-enkephalin concentrations in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and abstinent rats.
Tejwani GA; Rattan AK; Koo KL; Matwyshyn GA; Bhargava HN
Pharmacology; 1994 Apr; 48(4):216-25. PubMed ID: 8177908
[TBL] [Abstract][Full Text] [Related]
15. Effect of morphine tolerance and abstinence on the binding of [3H]naltrexone to discrete brain regions and spinal cord of the rat.
Reddy PL; Veeranna ; Matwyshyn GA; Thorat SN; Bhargava HN
Gen Pharmacol; 1994 Mar; 25(2):355-61. PubMed ID: 8026736
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and behavioral studies on the interaction between mu- and kappa-opiate agonists in mice.
Thorat SN; Veeranna ; Reddy PL; Bhargava HN
Brain Res; 1993 Jul; 615(2):191-8. PubMed ID: 8395957
[TBL] [Abstract][Full Text] [Related]
17. Effect of repeated administration of U-50,488H, a kappa opioid receptor agonist, on central 5-HT1 and 5-HT2 receptors in the rat.
Gulati A; Ramarao P; Bhargava HN
Pharmacology; 1989; 39(3):145-53. PubMed ID: 2587620
[TBL] [Abstract][Full Text] [Related]
18. Brain and spinal cord kappa opiate receptors and pharmacological responses to U-50,488H in rats of differing ages.
Bhargava HN; Matwyshyn GA; Reddy PL; Veeranna
Pharmacol Biochem Behav; 1994 May; 48(1):87-91. PubMed ID: 8029307
[TBL] [Abstract][Full Text] [Related]
19. Proliferation of thyrotropin releasing hormone receptors in specific brain regions during the development of hypertension in spontaneously hypertensive rats.
Bhargava HN; Das S; Bansinath M
Peptides; 1987; 8(2):231-5. PubMed ID: 3035513
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of the binding of 3H-(3-MeHis2) thyrotropin releasing hormone to rat amygdala membranes by some naturally occurring cannabinoids.
Bhargava HN; Gulati A
Peptides; 1988; 9(4):771-5. PubMed ID: 2852360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]